Year: 2015
Type: article
Abstract: BACKGROUND: Renin-angiotensin system activation is a feature of many cardiovascular conditions. Activity of myocardial reduced nicotinamide adenine dinucleotide phosphate oxidase 2 (NADPH oxidase 2 or Nox2) is enhanced by angiotensin II (Ang II) and contributes to increased hypertrophy, fibrosis, and adverse remodeling. Recent studies found that Nox2-mediated reactive oxygen species production modulates physiological cardiomyocyte function. OBJECTIVES: This study sought to investigate the effects of cardiomyocyte Nox2 on contractile function during increased Ang II activation. METHODS: We generated a cardiomyocyte-targeted Nox2-transgenic mouse model and studied the effects of in vivo and ex vivo Ang II stimulation, as well as chronic aortic banding. RESULTS: Chronic subpressor Ang II infusion induced greater cardiac hypertrophy in transgenic than wild-type mice but unexpectedly enhanced contractile function. Acute Ang II treatment also enhanced contractile function in transgenic hearts in vivo and transgenic cardiomyocytes ex vivo. Ang II-stimulated Nox2 activity increased sarcoplasmic reticulum (SR) Ca(2+) uptake in transgenic mice, increased the Ca(2+) transient and contractile amplitude, and accelerated cardiomyocyte contraction and relaxation. Elevated Nox2 activity increased phospholamban phosphorylation in both hearts and cardiomyocytes, related to inhibition of protein phosphatase 1 activity. In a model of aortic banding-induced chronic pressure overload, heart function was similarly depressed in transgenic and wild-type mice. CONCLUSIONS: We identified a novel mechanism in which Nox2 modulates cardiomyocyte SR Ca(2+) uptake and contractile function through redox-regulated changes in phospholamban phosphorylation. This mechanism can drive increased contractility in the short term in disease states characterized by enhanced renin-angiotensin system activation.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $7,166
Awards: Stretch-dependent X-ROS signaling: implications for cardiomyopathy, The roles of NOX4 and its crosstalk with C/EBPβ signaling in exercise-induced cardiac hypertrophy, Promoting cardiac proliferation within the adult mammalian heart by pharmacological inhibition of DUSP6- and GSK3ß-dependent signalling, The role of Nox4 in the regulation of maternal biomarkers of congenital heart defects, Redox-regulated adaptive pathways in heart failure (renewal), Research Excellence (round2) - King's College London, NADPH oxidases in cardiac hypertrophy and failure (renewal: years 11-15), Molecular mechanisms underlying NOX4-mediated cardiomyocyte differentiation
OpenAlex ID: W896549154
